Related Experiment Video
Updated: Aug 9, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea
R F Jacoby1, R J Alexander, R F Raicht
1Department of Medicine, University of Chicago, IL 60637.
Abstract:
We have been studying a rat model of colon cancer in which tumors are induced by direct application of N-methyl-N-nitrosourea (MNU) to discrete areas of the colonic mucosa for a limited period of time. Activation of the ras genes by point mutation has been observed in many experimental tumors, including tumors induced by MNU. To detect potential activating point mutations in the H-ras and K-ras oncogenes in MNU-induced rat colon tumors, DNA samples from 40 adenomas, nine carcinomas, and 14 histologically normal tissue samples from 14 rats--as well as from 16 foci induced on NIH3T3 cells by tumor DNAs--were amplified by the polymerase chain reaction and hybridized with allele-specific oligonucleotide probes. No H-ras point mutations were observed in any of these samples. We did detect K-ras point mutations, however, in four primary tumours--one adenoma (2.5%) and three carcinomas (33%); these mutations were all G----A transitions at the second nucleotide of codons 12 and 13. The absence of detectable ras mutations from the majority of tumors suggests that, in contrast to other animal models utilizing MNU, tumorigenesis in MNU-induced rat colon tumors may predominantly involve activation of genes other than ras.
Insights
Ras gene mutations are uncommon in N-methyl-N-nitrosourea (MNU)-induced rat colon tumors. Most tumors did not show ras mutations, suggesting other genes drive tumorigenesis in this model.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- N-methyl-N-nitrosourea (MNU) is used to induce colon cancer in a rat model.
- Ras gene mutations are frequently observed in experimental tumors, including those induced by MNU.
- Investigating ras oncogene activation is crucial for understanding colon tumorigenesis.
Purpose of the Study:
- To detect activating point mutations in H-ras and K-ras oncogenes in MNU-induced rat colon tumors.
- To determine the frequency and type of ras mutations in different stages of tumor development.
- To elucidate the role of ras gene mutations in MNU-induced rat colon cancer.
Main Methods:
- DNA samples from rat colon tumors (adenomas, carcinomas) and normal tissues were analyzed.
- Polymerase chain reaction (PCR) was used to amplify H-ras and K-ras oncogenes.
- Allele-specific oligonucleotide probes were employed for mutation detection.
Main Results:
- No activating point mutations were found in the H-ras oncogene in any samples.
- K-ras point mutations were detected in 4 out of 40 primary tumors (10% overall).
- Mutations in K-ras occurred in one adenoma (2.5%) and three carcinomas (33%), specifically G-to-A transitions at codons 12 and 13.
Conclusions:
- Ras gene mutations are infrequent in the majority of MNU-induced rat colon tumors.
- Tumorigenesis in this model may predominantly involve activation of genes other than ras.
- Findings contrast with other MNU-based models, highlighting unique aspects of rat colon cancer development.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

